VLNC Messages for Smoking
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn how a messaging campaign about reduced nicotine cigarettes and policy, combined with the use of very low nicotine cigarettes (VLNCs), affects smoking behavior and attitudes among adult smokers. The study also aims to assess the efficacy of the messages in different populations, including smokers with past-month serious psychological distress (SPD), low socioeconomic status (SES), and those in neither category. The primary hypothesis is: exposure to messages in combination with VLNC use will lead to less cigarettes use compared to VLNCs without messages. Researchers will compare: The effects of receiving VLNCs with messages (treatment group) to receiving VLNCs without messages (control group). Participants will: Complete a baseline survey and be randomly assigned to one of two groups: treatment (VLNCs + messages) or control (VLNCs only). Attend weekly study visits for surveys, breath samples, and receive supply of VLNCs , either with or without the messaging campaign. Complete brief daily surveys through text messages.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on smoking behavior and the use of very low nicotine cigarettes.
What data supports the effectiveness of the VLNC messages treatment for smoking cessation?
Text messaging interventions, like the VLNC messages, have shown promise in helping people quit smoking by increasing engagement and satisfaction, as seen in a study with Latino smokers where 30% achieved abstinence. Additionally, shorter, more direct messages have been effective in recruiting and helping people quit smoking.12345
Is it safe to use very low nicotine content (VLNC) cigarettes?
How is the VLNC Messages treatment for smoking different from other treatments?
VLNC Messages for smoking is unique because it uses text messaging to deliver smoking cessation support, which can be more accessible and engaging for users compared to traditional methods. This approach allows for real-time interaction and personalized support, making it a novel option for those looking to quit smoking.511121314
Eligibility Criteria
This trial is for adult smokers, including those with recent serious psychological distress or low socioeconomic status. Participants must be willing to attend weekly study visits and complete daily surveys via text message.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete a baseline survey, provide expired breath CO sample, and receive a 1-week supply of full nicotine cigarettes
Randomization
Participants are randomized into treatment or control groups and receive a 14-day supply of VLNCs
Treatment
Participants attend weekly visits to complete questionnaires, provide expired CO samples, and receive VLNCs with or without messages
Follow-up
Participants are monitored for smoking behavior and attitudes after the treatment phase
Treatment Details
Interventions
- Control message
- VLNC messages
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgia State University
Lead Sponsor
University of South Carolina
Collaborator
Emory University
Collaborator
National Cancer Institute (NCI)
Collaborator